ERNA Ernexa Therapeutics Inc.

Fundamentals / CIK 0000748592 / USD
Other share classes on CIK 0000748592: ERNAW

Ernexa Therapeutics Inc. reported $7.10M in total assets and a net loss of $13.96M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ERNA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$35.94M$17.97M$0-$116.6MFY 2016 Revenue: $22.31MFY 2016 Net Income: -$2.92M2016FY 2017 Revenue: $21.27MFY 2017 Net Income: -$1.08M2017FY 2018 Revenue: $23.34MFY 2018 Net Income: -$259K2018FY 2019 Revenue: $19.81MFY 2019 Net Income: -$2.05M2019FY 2020 Revenue: $5.80MFY 2020 Net Income: -$26.53M2020FY 2021 Net Income: -$122.5M2021FY 2022 Revenue: $0FY 2022 Net Income: -$24.58M2022FY 2023 Revenue: $68KFY 2023 Net Income: -$21.67M2023FY 2024 Revenue: $582KFY 2024 Net Income: -$44.54M2024FY 2025 Net Income: -$14.08M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $582K $68K $0 -- $5.80M $19.81M $23.34M $21.27M $22.31M
Cost of Revenue -- $96K $236K $0 -- -- -- -- -- --
Gross Profit -- $486K -$168K $0 -- -- -- -- -- --
Research & Development $4.16M $4.60M $5.92M $10.39M $12.71M $2.0K $26K $72K $139K --
Selling, General & Admin -- -- -- -- -- $8.09M $13.18M $14.46M $15.59M $16.46M
Total Operating Expenses $9.32M $16.16M $20.97M $33.22M $113.7M $26.49M $21.57M $23.13M $22.68M $24.59M
Operating Income -$9.32M -$15.67M -$21.14M -$33.22M -$113.7M -$26.49M -$1.76M $203K -$1.40M -$2.28M
EBITDA -$9.25M -$15.54M -$21.05M -$33.06M -$113.6M -$26.39M $1.11M $2.97M $915K $609K
Interest Income $100K $200K -- -- -- -- -- -- -- --
Interest Expense -$100K -$6.80M $614K $30K -- $118K $236K $296K $425K $517K
Income Before Tax -$14.13M -$44.51M -$21.67M -$24.53M -$122.5M -$26.53M -$2.02M -$323K -$1.01M -$2.88M
Income Tax Expense -$45K $30K -$3.0K $45K $64K $0 $27K -$64K $66K $38K
Net Income -$14.08M -$44.54M -$21.67M -$24.58M -$122.5M -$26.53M -$2.05M -$259K -$1.08M -$2.92M
Basic EPS -$20,740.74 -$453,333.33 -$566,666.67 -$1,119,444.44 -$7,862,500.00 -$4,194,444.44 -$4,000,000.00 -$555,555.56 -$2,500,000.00 -$8,555,555.56
Diluted EPS -$20,740.74 -$453,333.33 -$566,666.67 -$1,119,444.44 -$7,862,500.00 -$4,194,444.44 -$4,000,000.00 -$555,555.56 -$2,500,000.00 -$8,555,555.56
Basic Shares Outstanding 681 98 38 22 16 6 0 0 0 0
Diluted Shares Outstanding 681 98 38 22 16 6 0 0 0 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- -- -- $1.0K
Cost of Revenue $0 $0 -- -- $0 $0 -- $0
Gross Profit -- -- -- -- -- -- -- $1.0K
Research & Development $1.87M $2.79M $1.92M $676K $1.03M $1.14M $1.31M $1.16M
Total Operating Expenses $2.99M $4.10M $5.59M $2.09M $1.99M $2.50M $2.73M $2.70M
Operating Income -$2.99M -$4.10M -$5.59M -$2.09M -$1.99M -$2.50M -$2.73M -$2.70M
EBITDA -$2.98M -$4.09M -$5.58M -$2.08M -$1.98M -$2.48M -$2.71M -$2.68M
Interest Income $49K $55K $44K -- -- -- $5.0K --
Interest Expense -- -- -- $0 $0 $16K $800K -$10.10M
Income Before Tax -$2.94M -$4.01M -$5.55M -$1.56M -$1.23M -$3.14M -$8.19M -$5.75M
Income Tax Expense $0 $0 -$40K -$62K $6.0K $3.0K $8.0K $11K
Net Income -$2.94M -$4.01M -$5.51M -$1.50M -$1.24M -$3.14M -$8.20M -$5.76M
Basic EPS -$1.89 -$3.40 -$173.75 -- -$3.77 -$15.19 -$1,444.00 --
Diluted EPS -$1.89 -$3.40 -$173.75 -- -$3.77 -$15.19 -$1,444.00 --
Basic Shares Outstanding 1.6M 1.2M 31.7K -- 329.0K 207.0K 5.7K --
Diluted Shares Outstanding 1.6M 1.2M 31.7K -- 329.0K 207.0K 5.7K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.88M $1.73M $7.58M $11.45M $16.98M $777K $3.21M $2.54M $3.38M $5.69M
Cash & Short-Term Investments $1.88M $1.73M $7.58M $11.45M $16.98M $777K $3.21M $2.54M $3.38M $5.69M
Accounts Receivable, Net -- -- -- -- $684K $0 $1.20M $1.14M $714K $928K
Total Current Assets $3.13M $2.35M $9.60M $13.68M $18.77M $1.73M $6.07M $6.79M $9.64M $10.66M
Property, Plant & Equipment, Net $94K $85K $493K $236K $670K $594K $2.82M $4.67M $3.68M $3.10M
Goodwill $2.04M $2.04M $2.04M $2.04M $2.04M $2.04M $696K $667K $1.00M $937K
Intangible Assets -- -- -- -- -- -- $696K $667K $1.00M $29K
Other Non-Current Assets $110K $118K $120K $1.13M $488K $50K $97K $103K $16K $92K
Total Non-Current Assets $2.70M $2.92M $39.53M $8.60M $12.76M $12.04M $8.05M $8.08M $6.93M $6.03M
Total Assets $5.83M $5.27M $49.13M $22.28M $31.52M $13.78M $14.12M $14.86M $16.57M $16.70M
Accounts Payable $1.12M $1.72M $1.07M $1.62M $1.75M $1.27M $835K $271K $390K $247K
Short-Term Debt -- -- -- -- -- $1.50M $2.74M $1.00M $5.06M $2.99M
Deferred Revenue (Current) -- -- $190K $0 -- $76K $460K $1.37M $3.56M $1.06M
Other Current Liabilities $83K -- $1.21M $363K $247K $0 $419K $337K $192K $291K
Total Current Liabilities $3.11M $2.94M $6.57M $7.65M $3.68M $3.12M $6.09M $4.02M $10.75M $6.64M
Long-Term Debt -- -- -- -- -- $532K -- $2.75M $64K $5.12M
Deferred Revenue (Non-Current) -- -- $392K $0 -- $2.0K $2.0K $30K $63K $219K
Other Non-Current Liabilities $43K $111K $84K $94K $48K $23K $26K -- $52K $12K
Total Non-Current Liabilities $320K $630K $40.33M $2.52M $2.35M $22.23M $2.94M $3.92M $287K $5.98M
Total Liabilities $3.43M $3.57M $46.90M $10.17M $6.02M $25.36M $9.03M $7.95M $11.03M $12.63M
Total Debt (incl. Leases) $490K $684K $35.07M $1.18M $2.72M $4.23M $6.08M $7.29M $5.12M $8.11M
Common Stock $2.0K $17K $27K $26K $13K $0 $14K $14K $13K $11K
Retained Earnings -$245.6M -$231.5M -$187.0M -$165.3M -$140.7M -$37.38M -$131.5M -$129.4M -$129.1M -$128.0M
Accumulated Other Comp. Income -- -- -- -- -- $245K $268K $200K $345K $223K
Total Stockholders' Equity $2.40M $1.70M $2.23M $12.11M $25.50M $7.66M $9.74M $6.92M $5.54M $4.07M
Total Equity $2.40M $1.70M $2.23M $12.11M $25.50M $7.66M $9.74M $6.92M $5.54M $4.07M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $5.58M $5.03M $9.18M $1.88M $3.05M $4.32M $1.92M $1.73M
Cash & Short-Term Investments $5.58M $5.03M $9.18M $1.88M $3.05M $4.32M $1.92M $1.73M
Total Current Assets $6.73M $5.89M $10.00M $3.13M $3.38M $4.79M $2.21M $2.35M
Property, Plant & Equipment, Net $73K $82K $88K $94K $92K $50K $67K $85K
Goodwill -- -- -- $2.04M $2.04M $2.04M $2.04M $2.04M
Other Non-Current Assets $25K $25K $110K $110K $116K $117K $118K $118K
Total Non-Current Assets $376K $421K $547K $2.70M $2.79M $2.79M $2.85M $2.92M
Total Assets $7.10M $6.32M $10.54M $5.83M $6.17M $7.58M $5.06M $5.27M
Accounts Payable $1.36M $1.38M $1.30M $1.12M $958K $1.32M $1.27M $1.72M
Deferred Revenue (Current) -- -- -- -- -- -- $5.33M --
Other Current Liabilities -- $124K $218K $83K $63K $125K -- --
Total Current Liabilities $2.61M $2.93M $3.46M $3.11M $2.14M $2.65M $10.44M $2.94M
Other Non-Current Liabilities $1.0K $1.0K $1.0K $43K $112K $113K $111K $111K
Total Non-Current Liabilities $139K $183K $227K $320K $458K $489K $571K $630K
Total Liabilities $2.75M $3.12M $3.68M $3.43M $2.60M $3.14M $11.01M $3.57M
Total Debt (incl. Leases) $309K $349K $389K $490K $552K $593K $632K $684K
Common Stock $8.0K $6.0K $6.0K $2.0K $39K $37K $262K $17K
Retained Earnings -$258.1M -$255.2M -$251.1M -$245.6M -$244.1M -$242.9M -$239.7M -$231.5M
Total Stockholders' Equity $4.35M $3.20M $6.86M $2.40M $3.57M $4.44M -$5.95M $1.70M
Total Equity $4.35M $3.20M $6.86M $2.40M $3.57M $4.44M -$5.95M $1.70M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$14.08M -$44.54M -$21.67M -$24.58M -$122.5M -$26.53M -$2.05M -$259K -$1.08M -$2.92M
Depreciation & Amortization $65K $139K $84K $161K $117K $98K $2.88M $2.76M $2.32M $2.89M
Stock-Based Compensation $1.50M $1.52M $1.24M $2.94M $5.24M $91K $206K $443K $457K $419K
Change in Receivables -- -- -- -- -$659K $0 -$248K -$507K $142K -$83K
Operating Cash Flow -$7.02M -$15.84M -$20.41M -$20.98M -$23.49M -$8.10M $2.74M $1.36M $549K $23K
Capital Expenditure -$37K -$369K -$19K -$297K -$154K -$39K -$128K -$648K -$728K -$427K
Free Cash Flow -$7.05M -$16.20M -$20.43M -$21.27M -$23.64M -$8.14M $2.62M $717K -$179K -$404K
Investing Cash Flow -$37K -$365K -$19K -$47K -$22.74M -$39K -$1.06M -$1.58M -$1.45M -$840K
Common Stock Issued $4.93M $1.14M $0 $19.71M $0 $0 -- $1.38M $1.77M $2.69M
Financing Cash Flow $7.21M $6.26M $16.56M $19.58M $61.59M $4.67M -$1.10M -$303K -$1.47M $3.26M
Net Change in Cash $155K -$9.94M -$3.87M -$1.44M $15.36M -$2.63M $623K -$592K -$2.37M $2.44M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.94M -$4.01M -$5.51M -$1.50M -$1.24M -$3.14M -$8.20M -$5.76M
Depreciation & Amortization $10K $9.0K $8.0K $13K $17K $17K $18K $19K
Stock-Based Compensation $375K $320K $309K $333K $293K $368K $502K $410K
Operating Cash Flow -$3.17M -$4.15M -$2.26M -$1.15M -$1.27M -$2.53M -$2.06M -$3.54M
Capital Expenditure $0 -$3.0K -$2.0K -- -- -- -- $0
Free Cash Flow -$3.17M -$4.16M -$2.27M -- -- -- -- -$3.54M
Investing Cash Flow $0 -$3.0K -$2.0K -- -- -- -- $0
Common Stock Issued -- -- $10.48M -- -- $7.20M -- --
Financing Cash Flow $3.72M $6.0K $9.56M $0 $26K $4.93M $2.25M $1.01M
Net Change in Cash $547K -$4.15M $7.29M -$1.16M -$1.27M $2.40M $189K -$2.54M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 83.5% -247.1% -- -- -- -- -- -- --
Operating Margin -- -2693.1% -31080.9% -- -- -456.7% -8.9% 0.9% -6.6% -10.2%
Net Profit Margin -- -7652.7% -31864.7% -- -- -457.4% -10.3% -1.1% -5.1% -13.1%
Return on Equity (ROE) -586.6% -2618.4% -970.4% -203.0% -480.5% -346.4% -21.0% -3.7% -19.5% -71.9%
Return on Assets (ROA) -241.4% -845.3% -44.1% -110.3% -388.7% -192.6% -14.5% -1.7% -6.5% -17.5%
Current Ratio 1.01x 0.80x 1.46x 1.79x 5.10x 0.55x 1.00x 1.69x 0.90x 1.60x
Quick Ratio 0.61x 0.59x 1.15x 1.50x 4.81x 0.25x 0.72x 0.91x 0.38x 1.00x
Debt to Equity 0.20x 0.40x 15.71x 0.10x 0.11x 0.55x 0.62x 1.05x 0.93x 1.99x
Revenue Growth (YoY) -- +755.9% -- -- -- -70.7% -15.1% +9.7% -4.7% -9.0%
Operating Income Growth (YoY) -- -- -- -- -- -- -968.0% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -395.2% +101.0% +148.6% +2287.0% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -411.2% +264.9% -- -- --
10Y Revenue / Share Growth -- -- -99.9% -- -- -58.0% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- -- -- -- 83.5%
Operating Margin -- -- -- -- -- -- -- -2693.1%
Net Profit Margin -- -- -- -- -- -- -- -7652.7%
Return on Equity (ROE) -320.8% -383.0% -166.0% -586.5% -513.7% -983.7% -- -2618.4%
Return on Assets (ROA) -196.5% -194.1% -108.0% -241.4% -297.1% -576.3% -911.1% -845.3%
Current Ratio 2.57x 2.01x 2.89x 1.01x 1.58x 1.81x 0.21x 0.80x
Quick Ratio 2.13x 1.71x 2.65x 0.61x 1.42x 1.63x 0.18x 0.59x
Debt to Equity 0.07x 0.11x 0.06x 0.20x 0.15x 0.13x -- 0.40x
Revenue Growth (YoY) -- -- -- -- -- -- -- -94.1%
Source: SEC EDGAR CompanyFacts (CIK 0000748592) · from June 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal